# FDA EIR - KITE PHARMA INC - January 28, 2022

Source: https://www.globalkeysolutions.net/records/eir/kite-pharma-inc/cace98d5-83ee-415e-90c4-f5b9e5373e39

> FDA EIR for KITE PHARMA INC on January 28, 2022. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: KITE PHARMA INC
- Inspection Date: 2022-01-28
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/sarah-t-sherman/0136b033-eb1b-4eab-a48e-dd66be0947b4)
- [issuing_officer](https://www.globalkeysolutions.net/people/kaitlyn-t-dang/640abfda-d492-4136-b11d-59ed9016bd97)
- [company_representative](https://www.globalkeysolutions.net/people/lauryn-n-uribe/81dbec7a-02db-4199-a5d8-4a10589fbc58)
- [company_representative](https://www.globalkeysolutions.net/people/kate-brock/8c2ca3f5-cd70-4139-b2a6-43e309395804)
- [investigator](https://www.globalkeysolutions.net/people/comyar-shoghi/c172c1bc-deea-4bed-a3cf-5493d72ce6c3)

Company: https://www.globalkeysolutions.net/companies/kite-pharma-inc/dcb874e6-c0b9-4398-85d8-d50edd95cca6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d